Registration number: 12062775

GI Medic Ltd

Contents

Company Information	1
Abridged Balance Sheet	2
Notes to the Unaudited Abridged Financial Statements	3 to 8

GI Medic Ltd

Company Information

Director

Dr Ravi Misra

Registered office

21 Vaughan Avenue, London, United Kingdom, NW4 4HT

Accountants

Charles Rippin and Turner Limited Charles Rippin & Turner Middlesex House 130 College Road Harrow Middlesex HA1 1BQ

GI Medic Ltd

(Registration number: 12062775)
Abridged Balance Sheet as at 30 June 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	62,008	22,570
Current assets
Debtors		38,128	42,109
Cash at bank and in hand		67,634	47,892
		105,762	90,001
Creditors: Amounts falling due within one year		(15,272)	(18,671)
Net current assets		90,490	71,330
Total assets less current liabilities		152,498	93,900
Accruals and deferred income		(4,085)	(1,890)
Net assets		148,413	92,010
Capital and reserves
Called up share capital	5	100	100
Retained earnings		148,313	91,910
Shareholders' funds		148,413	92,010

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 16 July 2025
 

......................................... Dr Ravi Misra Director

GI Medic Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

1	General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
21 Vaughan Avenue, London,
United Kingdom,
NW4 4HT

These financial statements were authorised for issue by the director on 16 July 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

GI Medic Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office equipment	20% WDV
Plant and machinery	20% WDV

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

GI Medic Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

GI Medic Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

4	Tangible assets

	Furniture, fittings and equipment  £	Other tangible assets £	Total £
Cost or valuation
At 1 July 2024	800	36,725	37,525
Additions	3,398	41,234	44,632
Disposals	-	(14,390)	(14,390)
At 30 June 2025	4,198	63,569	67,767
Depreciation
At 1 July 2024	538	14,417	14,955
Charge for the year	732	4,462	5,194
Eliminated on disposal	-	(14,390)	(14,390)
At 30 June 2025	1,270	4,489	5,759
Carrying amount
At 30 June 2025	2,928	59,080	62,008
At 30 June 2024	262	22,308	22,570

5	Share capital

Allotted, called up and fully paid shares

	2025		2024
	No.	£	No.	£
Ordinary shares - 75 A of £1 each	75	75	75	75
Ordinary shares - 9 B of £1 each	9	9	9	9
Ordinary shares - 8 C of £1 each	8	8	8	8
Ordinary shares - 8 D of £1 each	8	8	8	8
	100	100	100	100

6

Dividends

Interim dividends paid

		2025 £		2024 £
Interim dividend of 3,000.00 (2024 - 5,100.00) per each Ordinary Shares		30,000		51,000

GI Medic Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

7	Related party transactions

GI Medic Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

Director's remuneration

The director's remuneration for the year was as follows:

	2025 £	2024 £
Compensation for loss of office	15,918	16,611